Phase I/II Clinical Study of Forodesine in Japanese Recurrent/Refractory Peripheral T-cell Lymphoma Patients
This study is currently recruiting participants.
Verified March 2013 by Mundipharma K.K.
Sponsor:
Mundipharma K.K.
Information provided by (Responsible Party):
Mundipharma K.K.
ClinicalTrials.gov Identifier:
NCT01776411
First received: January 22, 2013
Last updated: March 8, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2014 |
| Estimated Primary Completion Date: | December 2014 (Final data collection date for primary outcome measure) |